Trial intelligence / Profile preview

Interest of in Situ Terlipressin Administration Before Bronchial Biopsy

NCT02970175Phase 3Completed

Sponsor
Rouen University Hospital
Start
Jun 2017
Primary completion
Apr 2024
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of terlipressin (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Number of biopsy realized during the endoscopy at Day 1. Started Jun 2017; status: completed.

02

Drugs

terlipressin

Beyond the preview

Go deeper on NCT02970175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02970175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call